Hollings Renton, Director at ANAPTYSBIO, INC (ANAB), sold 20,462 shares at $19.44 ($401K) on 2025-08-08, disclosed to the SEC on 2025-08-12.
Scheduled sale ($401k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.44 | 3,110 | $60K | 15.1% |
| 2 | $19.44 | 3,110 | $60K | 15.1% |
| 3 | $19.70 | 7,121 | $140K | 34.9% |
| 4 | $19.70 | 7,121 | $140K | 34.9% |
| Total | $19.62 avg | 20,462 | $401K | 100% |
| Filing → |
| ANAB | SELL | 2024-12-03 | $250K | — | Filing → |
| ANAB | SELL | 2024-07-17 | $613K | — | Filing → |
| ANAB | SELL | 2024-06-18 | $45K | — | Filing → |